UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BIOSYNTHESIS OF FLUOROTHREONINE AND FLUOROACETIC: ACID BY THE THIENAMYCIN PRODUCER, STREPTOMYCES CATTLEYA

The Journal of Antibiotics, 1986, Vol.39(2), pp.259-265

1986

Volltextzugriff (PDF)

COMPARISON OF TRANSPORT PATHWAYS OF CATECHOL-SUBSTITUTED CEPHALOSPORINS, BO-1236 AND BO-1341, THROUGH THE OUTER MEMBRANE OF ESCHERICHIA COLI

The Journal of Antibiotics, 1990/12/25, Vol.43(12), pp.1617-1620

1990

Volltextzugriff (PDF)

β-ETHYNYLSERINE, AN ANTIMETABOLITE OF L-THREONINE, FROM STREPTOMYCES CATTLEYA

The Journal of Antibiotics, 1986, Vol.39(2), pp.304-305

1986

Volltextzugriff (PDF)

DIFFERANISOLE A, A NEW DIFFERENTIATION INDUCING SUBSTANCE

The Journal of Antibiotics, 1985, Vol.38(8), pp.1100-1102

1985

Volltextzugriff (PDF)

Pharmacokinetics and safety of BO-2727, a new injectable 1-β-methyl carbapenem antibiotic, and its effect on the faecal microflora in healthy male volunteers

Journal of antimicrobial chemotherapy, 1994-05, Vol.33 (5), p.987-998

Nakashima, Mitsuyoshi

1994

Volltextzugriff (PDF)

In-vitro activity of imipenem combined with β-lactam antibiotics for methicillin-resistant Staphylococcus aureus

Journal of antimicrobial chemotherapy, 1991-06, Vol.27 (6), p.809-815

1991

Volltextzugriff (PDF)

Synergic activity of imipenem/cilastatin combined with cefotiam against methiclillin-resistant Staphylococcus aureus

Journal of antimicrobial chemotherapy, 1993-04, Vol.31 (4), p.533-541

1993

Volltextzugriff (PDF)

Autoregulation of Renal Circulation

Japanese Heart Journal, 1965, Vol.6(3), pp.243-255

1965

Volltextzugriff (PDF)

Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy

Journal of radiation research, 2023-01, Vol.64 (1), p.91-98

2023

Volltextzugriff (PDF)

Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy

Biochemical and biophysical research communications, 2021-06, Vol.559, p.210-216

2021

Volltextzugriff (PDF)

Phospholipid‐Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy

Chembiochem : a European journal of chemical biology, 2023-08, Vol.24 (15), p.e202300186-n/a

2023

Volltextzugriff (PDF)

A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients

The journal of obstetrics and gynaecology research, 2019-10, Vol.45 (10), p.2021-2028

2019

Volltextzugriff (PDF)

Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes

Genetics in medicine, 2017-07, Vol.19 (7), p.796-802

2017

Volltextzugriff (PDF)

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness

Journal of radiation research, 2020-11, Vol.61 (6), p.876-885

2020

Volltextzugriff (PDF)

The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy

Journal of radiation research, 2023-03, Vol.64 (2), p.399-411

2023

Volltextzugriff (PDF)

Proteomic Characterization of SAS Cell-Derived Extracellular Vesicles in Relation to Both BPA and Neutron Irradiation Doses

Cells (Basel, Switzerland), 2023-06, Vol.12 (12), p.1562

2023

Volltextzugriff (PDF)

HIF-1α affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA

International journal of radiation biology, 2021-10, Vol.97 (10), p.1441-1449

2021

Volltextzugriff (PDF)

Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy

Biology (Basel, Switzerland), 2022-03, Vol.11 (3), p.420

2022

Volltextzugriff (PDF)

High Body Mass Index is an Important Risk Factor for the Development of Type 2 Diabetes

Internal Medicine, 2012, Vol.51(14), pp.1821-1826

2012

Volltextzugriff (PDF)

Correction: Imamichi et al. Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. Biology 2022, 11, 420

Biology (Basel, Switzerland), 2023-08, Vol.12 (8), p.1112

2023

Volltextzugriff (PDF)

Effect of a change in reactor power on response of murine solid tumors in vivo, referring to impact on quiescent tumor cell population

International journal of radiation biology, 2019-05, Vol.95 (5), p.635-645

2019

Volltextzugriff (PDF)

Development of the Japanese version of the Pediatric Quality of Life Inventory™ Transplant Module

Pediatrics international, 2017-01, Vol.59 (1), p.80-88

2017

Volltextzugriff (PDF)

A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency

Experimental hematology, 2022-05, Vol.109, p.11-17

2022

Volltextzugriff (PDF)

HER‐2‐Targeted Boron Neutron Capture Therapy with Carborane‐integrated Immunoliposomes Prepared via an Exchanging Reaction

Chemistry : a European journal, 2023-12, Vol.29 (72), p.e202302486-n/a

2023

Volltextzugriff (PDF)

The impact of TP53 status of tumor cells including the type and the concentration of administered [.sup.10]B delivery agents on compound biological effectiveness in boron neutron capture therapy

Journal of radiation research, 2023-03, Vol.64 (2), p.399

2023

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(141)
Buchkapitel
(1)

Sprache

Englisch
(124)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

BIOSYNTHESIS OF FLUOROTHREONINE AND FLUOROACETIC: ACID BY THE THIENAMYCIN PRODUCER, STREPTOMYCES CATTLEYA

COMPARISON OF TRANSPORT PATHWAYS OF CATECHOL-SUBSTITUTED CEPHALOSPORINS, BO-1236 AND BO-1341, THROUGH THE OUTER MEMBRANE OF ESCHERICHIA COLI

β-ETHYNYLSERINE, AN ANTIMETABOLITE OF L-THREONINE, FROM STREPTOMYCES CATTLEYA

DIFFERANISOLE A, A NEW DIFFERENTIATION INDUCING SUBSTANCE

Pharmacokinetics and safety of BO-2727, a new injectable 1-β-methyl carbapenem antibiotic, and its effect on the faecal microflora in healthy male volunteers

In-vitro activity of imipenem combined with β-lactam antibiotics for methicillin-resistant Staphylococcus aureus

Synergic activity of imipenem/cilastatin combined with cefotiam against methiclillin-resistant Staphylococcus aureus

Autoregulation of Renal Circulation

Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy

Tumor-targeting hyaluronic acid/fluorescent carborane complex for boron neutron capture therapy

Phospholipid‐Coated Boronic Oxide Nanoparticles as Boron Agents for Boron Neutron Capture Therapy

A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients

Clinical utility of next-generation sequencing for inherited bone marrow failure syndromes

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness

The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy

Proteomic Characterization of SAS Cell-Derived Extracellular Vesicles in Relation to Both BPA and Neutron Irradiation Doses

HIF-1α affects sensitivity of murine squamous cell carcinoma to boron neutron capture therapy with BPA

Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy

High Body Mass Index is an Important Risk Factor for the Development of Type 2 Diabetes

Correction: Imamichi et al. Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. Biology 2022, 11, 420

Effect of a change in reactor power on response of murine solid tumors in vivo, referring to impact on quiescent tumor cell population

Development of the Japanese version of the Pediatric Quality of Life Inventory™ Transplant Module

A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency

HER‐2‐Targeted Boron Neutron Capture Therapy with Carborane‐integrated Immunoliposomes Prepared via an Exchanging Reaction

The impact of TP53 status of tumor cells including the type and the concentration of administered [.sup.10]B delivery agents on compound biological effectiveness in boron neutron capture therapy

Suchergebnisse filtern